oxamflatin and belinostat

oxamflatin has been researched along with belinostat* in 1 studies

Other Studies

1 other study(ies) available for oxamflatin and belinostat

ArticleYear
A sensitive and specific liquid chromatography-tandem mass spectrometric method for determination of belinostat in plasma from liver cancer patients.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2010, Sep-15, Volume: 878, Issue:26

    A novel, sensitive and reliable liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed and validated for the determination of belinostat (PXD101) in human plasma. Oxamflatin was used as the internal standard. Liquid-liquid extraction of the plasma sample was performed using tert-butyl methyl ether as the organic solvent. Chromatographic separation was achieved on a BDS Hypersil C18 column (2.1 mm x1 00 mm, 5 microm) using gradient elution mode using 0.05% formic acid in water and 0.05% formic acid in acetonitrile as solvents A and B, respectively, 60/40. The run time was 6 min. The mass spectrometer was operated under a positive electrospray ionization condition and a multiple reaction monitoring mode. An excellent linear calibration was achieved in the range of 0.5-1000 ng/mL. An average recovery of belinostat for four quality controls was 72.6% and the recovery of the internal standard at 1000 ng/mL was 67.8%. The intra-day and inter-day precisions for belinostat were

    Topics: Antineoplastic Agents; Chemical Fractionation; Chromatography, Liquid; Clinical Trials as Topic; Humans; Hydroxamic Acids; Least-Squares Analysis; Liver Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Sulfonamides; Tandem Mass Spectrometry

2010